Značka Novo Nordisk končí. Výrobce Ozempicu hledá cestu z krize, zvolil vyzkoušený krok

Danish pharmaceutical company Novo Nordisk, known as the manufacturer of insulin and weight loss drugs Ozempic and Wegovy, is changing its name to the simpler "Novo". The rebranding is purely a marketing move, while the company will retain the original name Novo Nordisk in legal documents. The change includes a new slogan "The Novo Way" and a logo update where the sacred bull Apis will move in the opposite direction. Novo Nordisk has been experiencing stagnation in recent years - while its shares have lost more than 70% of their value over the past two years, competitor American company Eli Lilly is growing rapidly with share increases of over 400% in five years. Novo Nordisk is the ninth pharmaceutical company and the hundredth company overall with a market value slightly exceeding 191 billion dollars, while Eli Lilly is the first pharmaceutical company with a market value exceeding one trillion dollars.